FDA expands approved use of Opdivo in advanced lung cancer

09 Oct 2015 6:27 PM | Lori Aubrey (Administrator)
FDA expands approved use of Opdivo in advanced lung cancer

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm466413.htm

Comments

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software